Literature DB >> 8621793

Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.

K T Kalogeras1, L K Nieman, T C Friedman, J L Doppman, G B Cutler, G P Chrousos, R L Wilder, P W Gold, J A Yanovski.   

Abstract

Arginine vasopressin (AVP) acts synergistically with corticotropin-releasing hormone (CRH) to stimulate ACTH release from the anterior pituitary. In a previous study of bilateral simultaneous inferior petrosal sinus (IPS) sampling in healthy human subjects, we observed lateralized ACTH secretion, suggesting lateralized secretion of an ACTH-regulating hypothalamic factor. To investigate this possibility, we measured ACTH, CRH, AVP, and oxytocin (OT) levels in the IPS and the peripheral circulation in nine normal volunteers, before and after 1 microgram/kg i.v. bolus ovine CRH (oCRH). At baseline, ACTH, AVP, and OT exhibited a significant (P < 0.05) two to threefold intersinus gradient (ISG), indicating the existence of a dominant petrosal sinus. Endogenous CRH was undetectable in all samples. Despite similar exogenous oCRH levels in both petrosal sinuses, oCRH caused a significant increase (P < 0.001) in the ACTH ISG (15.8 +/- 5.6, mean +/- SEM), suggesting increased responsiveness of one dominant side of the anterior pituitary. This was associated with an ipsilateral CRH-induced AVP release and a significant increase (P < 0.01) in the AVP ISG (8.6 +/- 2.3), suggesting lateralized AVP secretion by the hypothalamus. Furthermore, the increased AVP ISG after oCRH correlated strongly with the ACTH ISG (r = 0.92, P < 0.01). oCRH administration did not affect OT. These findings suggest that there is a dominant petrosal sinus in healthy volunteers that appears to reflect a dominant side of the adenohypophysis, characterized by increased functional activity and/or responsiveness of the pituitary corticotrophs. This may reflect lateralized hypothalamic and/or suprahypothalamic function resulting in CRH-responsive lateralized secretion of AVP from parvocellular and/or magnocellular axons in the median eminence and the posterior pituitary. Although the functional and teleologic significance of these findings remains to be investigated, our data suggest a novel mechanism for CRH-mediated ACTH release, namely CRH-induced release of AVP which then enhances CRH action on the corticotrophs. Furthermore, our data represent the first direct evidence for the concept of brain lateralization with respect to neuroendocrine secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621793      PMCID: PMC507278          DOI: 10.1172/JCI118640

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  The syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  F C Bartter; W B Schwartz
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

2.  Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women.

Authors:  J A Amico; J M Johnston; A H Vagnucci
Journal:  Endocr Res       Date:  1994-02       Impact factor: 1.720

3.  Neuroendocrine brain asymmetry and physical complaints.

Authors:  W Wittling; E Schweiger
Journal:  Neuropsychologia       Date:  1993-06       Impact factor: 3.139

4.  Microinjections of corticotropin-releasing hormone into the medial parabrachial nucleus facilitate plasma vasopressin in cats.

Authors:  D E Carlson; A M Nabavian; L M Brown; D S Gann
Journal:  Ann N Y Acad Sci       Date:  1993-07-22       Impact factor: 5.691

5.  Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.

Authors:  R S Rittmaster; G B Cutler; D O Sobel; D S Goldstein; M C Koppelman; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

6.  Pathophysiologic and pharmacologic alterations in the release and action of ADH.

Authors:  A M Moses; M Miller; D H Streeten
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

7.  Denervation of the rat posterior pituitary gland: validation of a stereotaxic method.

Authors:  G B Makara
Journal:  J Neuroendocrinol       Date:  1993-08       Impact factor: 3.627

8.  Increased plasma arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids.

Authors:  A B Ahmed; B C George; C Gonzalez-Auvert; J F Dingman
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

9.  The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology.

Authors:  J A Yanovski; G B Cutler; J L Doppman; D L Miller; G P Chrousos; E H Oldfield; L K Nieman
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

10.  Simultaneous bilateral venous sampling for adrenocorticotropin in pituitary-dependent cushing's disease: evidence for lateralization of pituitary venous drainage.

Authors:  A Manni; R F Latshaw; R Page; R J Santen
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

View more
  5 in total

1.  Inferior petrosal sinus ACTH and prolactin responses to CRH in ACTH-dependent Cushing's syndrome: a single centre experience from the United Kingdom.

Authors:  Christina Daousi; Thomas Nixon; Mohsen Javadpour; Katharine Hayden; Ian A MacFarlane
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

2.  5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men.

Authors:  R Volpi; P Chiodera; N Giuliani; L Capretti; G Caffarri; M G Magotti; V Coiro
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

Review 3.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

4.  The contribution of type 2 diabetes mellitus to hypothalamic inflammation and depressive disorders in young patients with obesity.

Authors:  Guan-Zhong Dong; Qiao-Yang Zhang; Yu-Wen Jiao; Yi Ma; Shu-Min Zhu; Li-Hao Zhang; Min Zhang; Yun Chen; Xin-Hua Ye; Yin Cao; Li-Ming Tang
Journal:  Ann Transl Med       Date:  2022-02

Review 5.  The left-right side-specific endocrine signaling in the effects of brain lesions: questioning of the neurological dogma.

Authors:  Georgy Bakalkin
Journal:  Cell Mol Life Sci       Date:  2022-10-11       Impact factor: 9.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.